garenoxacin has been researched along with Seizures in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hayashi, K; Kawamura, Y; Takahata, M; Todo, Y | 1 |
| Fukuda, H; Kawamura, Y; Morita, Y; Nakamura, T; Soumi, K | 1 |
2 other study(ies) available for garenoxacin and Seizures
| Article | Year |
|---|---|
Synthesis, antibacterial activity, and toxicity of 7-(isoindolin-5-yl)-4-oxoquinoline-3-carboxylic acids. Discovery of the novel des-F(6)-quinolone antibacterial agent garenoxacin (T-3811 or BMS-284756).
Topics: Animals; Anti-Infective Agents; Bacteria; Fluoroquinolones; Indicators and Reagents; Indoles; Injections, Intraventricular; Magnetic Resonance Spectroscopy; Mice; Microbial Sensitivity Tests; Micronucleus Tests; Mutagens; Quinolones; Seizures; Structure-Activity Relationship | 2002 |
Pharmacological evaluation of garenoxacin, a novel des-F(6)-quinolone antimicrobial agent: effects on the central nervous system.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Central Nervous System; Drug Interactions; Fluoroquinolones; gamma-Aminobutyric Acid; Injections, Intravenous; Injections, Intraventricular; Male; Mice; Models, Animal; Quinolones; Rats; Rats, Wistar; Receptors, GABA; Seizures | 2003 |